Clinical Trials Directory

Trials / Completed

CompletedNCT02298023

Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear)

Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells: Phase II Double-Blind Placebo-Controlled Randomized Clinical Trials.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Main purpose of this study is to evaluate efficacy of allogenic adipose-derived mesenchymal stem cells in treatment of tendon injury. ALLO-ASC will be administrated to the patients with supraspinatus partial thickness tear by ultrasonographic guided injection.

Detailed description

Injection volume depends on the size of lesion on ultrasound examination. And all injection will be done under ultrasound guidance. Double blind Randomized placebo controlled study will be done with following 3 groups. Each group will have 8 people, so, the total patients will be 24 people. 1. Stem cell treatment group : stem cell 0.5cc (Total: 10 million cells) + Fibrin glue 0.5cc + range of motion exercise 2. Active control (fibrin glue) group : Normal saline 0.5cc + Fibrin glue 0.5cc + range of motion exercise 3. Control (normal saline) group : Normal saline 0.5cc + Normal saline 0.5cc + range of motion exercise The investigators will compare the efficacy difference with VAS(visual analog scale, primary outcome), ASES(American Shoulder and Elbow Surgeons) Score, UCLA(University of California, Los Angles) Shoulder Score, DASH(The Disabilities of the Arm, Shoulder and Hand) Score and change of tear size compared to the baseline image assessed by MRI. These measurement will be done at 6 and 12 weeks after injections and long-term follow-up will be also planned to 6 months, 12months and 24 months except for the evaluation of the tear size which will be done at baseline, 3 months and 24 months after the intervention.

Conditions

Interventions

TypeNameDescription
BIOLOGICALallogenic adipose stem cell injectionIntervention will be done with stem cell injection, 0.5cc (Total: 10 million cells), fibrin glue injection 0.5cc and range of motion exercise.
BIOLOGICALfibrin glue/normal saline injectionTotal 1cc of fibin glue and normal saline mixture injection and range of motion exercise
BIOLOGICALnormal saline injectionTotal 1cc of normal saline injection and range of motion exercise

Timeline

Start date
2014-09-01
Primary completion
2016-07-19
Completion
2018-04-10
First posted
2014-11-21
Last updated
2021-10-19
Results posted
2021-06-30

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02298023. Inclusion in this directory is not an endorsement.